IceCure Medical (ICCM) announced that its board of directors approved a rights offering to all holders of record of the company’s ordinary shares as of 5:00 p.m. Eastern Time on July 9, 2025. Under the Rights Offering, each holder of the company’s ordinary shares as of the Record Date will receive one right for each ordinary share held. Each Subscription Right will entitle the holder to subscribe for 0.1703 of a unit, each comprised of one ordinary share and a warrant to purchase one ordinary share at a subscription price of $1.00 per unit or, in lieu of such unit, one unit, each comprised of one pre-funded warrant to purchase one ordinary share and one warrant to purchase one ordinary share, at a subscription price of $0.9999 per unit. No fractional Subscription Rights are being distributed and no fractional units will be issued upon the exercise of any Subscription Rights in the Rights Offering. Shareholders must exercise Subscription Rights for at least one whole unit to participate in the Rights Offering. The Subscription Rights will expire if they are not exercised by 5:00 p.m., Eastern Time, on July 28, 2025, the expected expiration date of the Rights Offering. The company may extend the period for exercising the Subscription Rights. Subscription Rights which are not exercised by the expiration date of the Rights Offering will expire and will have no value.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCM:
- IceCure Medical Secures U.S. Patent Allowance for Cryogen Flow Control
- IceCure receives Notice of Allowance from USPTO for ‘Cryogen Flow Control’
- Buy Rating for Icecure Medical: Anticipated FDA Approval and Strategic Partnerships Drive Positive Outlook
- IceCure Medical Reports Q1 2025 Financial Results
- IceCure Medical’s Earnings Call: Optimism Amid Challenges